RATIOS
Senores Pharmaceuticals Ltd.
BSE
Jun 06
533.05
+6.75 (+ 1.28%)
Volume
47089
Prev. Close
526.30
Open Price
525.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 06
532.90
+7.15 (+ 1.36%)
Volume
387534
Prev. Close
525.75
Open Price
528.20
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Ratio Analysis
for the last 5 years.
|
ISIN No
|
INE0RB801010
|
Market Cap. ( ₹ in Cr. )
|
2454.20
|
P/BV
|
8.07
|
Book Value ( ₹ )
|
66.07
|
|
BSE Code
|
544319
|
52 Week High/Low ( ₹ )
|
665/435
|
FV/ML
|
10/1
|
P/E(X)
|
41.91
|
|
NSE Code
|
SENORESEQ
|
Book Closure
|
|
EPS ( ₹ )
|
12.72
|
Div Yield (%)
|
0.00
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 1.02 | 0.35 | 1.26 | 0.53 | 4.07 |
| Diluted EPS (Rs.) | 1.02 | 0.32 | 0.95 | 0.53 | 4.07 |
| Cash EPS (Rs.) | 1.47 | 0.93 | 2.17 | 0.99 | 3.69 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 153.74 | 55.11 | 39.65 | 38.60 | 24.91 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 153.74 | 55.11 | 39.65 | 38.60 | 24.91 |
| Revenue From Operations / Share (Rs.) | 8.37 | 11.15 | 12.61 | 18.13 | 20.81 |
| PBDIT / Share (Rs.) | 3.19 | 2.22 | 5.10 | 2.26 | 3.06 |
| PBIT / Share (Rs.) | 2.52 | 1.56 | 4.16 | 1.60 | 1.58 |
| PBT / Share (Rs.) | 1.11 | 0.66 | 1.98 | 1.03 | 1.05 |
| Net Profit / Share (Rs.) | 0.80 | 0.26 | 1.22 | 0.33 | 2.20 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 38.16 | 19.95 | 40.47 | 12.45 | 14.73 |
| PBIT Margin (%) | 30.17 | 13.95 | 32.95 | 8.81 | 7.58 |
| PBT Margin (%) | 13.25 | 5.98 | 15.67 | 5.70 | 5.05 |
| Net Profit Margin (%) | 9.57 | 2.39 | 9.68 | 1.84 | 10.57 |
| Return on Networth / Equity (%) | 0.52 | 0.48 | 3.08 | 0.86 | 8.83 |
| Return on Capital Employeed (%) | 1.46 | 2.43 | 6.28 | 3.89 | 4.73 |
| Return On Assets (%) | 0.44 | 0.28 | 1.07 | 0.53 | 5.58 |
| Long Term Debt / Equity (X) | 0.10 | 0.11 | 0.62 | 0.06 | 0.33 |
| Total Debt / Equity (X) | 0.13 | 0.55 | 1.55 | 0.42 | 0.39 |
| Asset Turnover Ratio (%) | 0.06 | 0.17 | 0.14 | 0.45 | 0.00 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 9.99 | 0.44 | 0.59 | 0.81 | 3.58 |
| Quick Ratio (X) | 9.78 | 0.39 | 0.52 | 0.77 | 3.43 |
| Inventory Turnover Ratio (X) | 1.10 | 1.48 | 0.18 | 0.00 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 2.26 | 2.50 | 2.34 | 4.01 | 5.84 |
| Interest Coverage Ratio (Post Tax) (%) | 1.57 | 1.30 | 1.56 | 1.59 | 5.19 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 2371.76 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 61.54 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 161.23 | 0.00 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 68.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 3.73 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 68.44 | 0.00 | 0.00 | 0.00 | 0.00 |